CDX-6114

DRUG2 trials

Sponsors

Codexis Inc.

Conditions

Healthy

Phase 1

Safety and Tolerability of CDX-6114 in Healthy Volunteers

CompletedNCT03577886

Codexis Inc.Healthy

Start: 2018-07-04End: 2018-09-04Updated: 2018-09-20

A Study of the Safety and Tolerability of CDX-6114 in Healthy Volunteers

CompletedNCT03797664

Codexis Inc.Healthy

Start: 2018-12-14End: 2019-04-12Updated: 2021-08-04